Found 34 matching trials
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma PHASE2 The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Learn More & Join Trial
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer PHASE2 This is a phase II clinical study evaluating the safety, tolerability, phar...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study PHASE2 This study is testing a new medicine called AK112 (Yivoximab) for people wi...
Show More Status
Enrolling By Invitation
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer NA The investigators propose to conduct a single-center, single-arm, Phase I c...
Show More Status
Active Not Recruiting
Location
Colorectal Cancer, West China Hospital
Learn More & Join Trial
Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors PHASE1 To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma PHASE1 This is a Phase Ib/II, open-label, single arm trial to evaluate the efficac...
Show More Status
Active Not Recruiting
Location
West China Hospital
Learn More & Join Trial
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma PHASE2 CMN-001 is an autologous, tumor antigen-loaded dendritic cell immunotherapy...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection PHASE2 This is an open label, multi-center, single arm study to evaluate the effic...
Show More Location
Anhui province hospital
Learn More & Join Trial
RegoNivo vs Standard of Care Chemotherapy in AGOC PHASE3 To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial